FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805081221> ?p ?o ?g. }

• W2805081221 endingPage "125" @default.
• W2805081221 startingPage "110" @default.
• W2805081221 abstract "Best Practices in Neurological Care Brain tumor managementSeema Nagpal, Scott G Soltys, Gordon Li, Griffith Harsh & Lawrence RechtSeema NagpalSeema Nagpal is a Clinical Assistant Professor of Neurology at the Stanford University School of Medicine (CA, USA) with specialization in neurooncology. She conducts clinical research with the goal of increasing both the quality and quantity of life for patients with neurooncological issues.Search for more papers by this author, Scott G SoltysScott G Soltys is a Clinical Assistant Professor in Radiation Oncology at the Stanford University School of Medicine. His research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of tumors of the brain and spine.Search for more papers by this author, Gordon LiGordon Li is an Assistant Professor in the Department of Neurosurgery at the Stanford University School of Medicine. His clinical expertise lies in the surgical treatment of brain tumors. His clinical research focuses on advancing techniques for the treatment of brain tumors and tumor immunotherapy.Search for more papers by this author, Griffith HarshGriffith Harsh is Professor of Neurological Surgery at the Stanford University School of Medicine. He directs the Stanford Brain Tumor Program and the Neurosurgery Residency Training Program.Search for more papers by this author & Lawrence RechtLawrence Recht is Professor of Neurology at the Stanford University School of Medicine. He specializes in the care of patients with brain tumors and neurological complications of cancer.Search for more papers by this authorPublished Online:4 Feb 2014https://doi.org/10.2217/ebo.13.309AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInReddit View chapterAbstract: ‘Brain tumor’ is a broad and inclusive term that includes both benign and aggressive primary tumors of the brain parenchyma, metastatic disease and tumors of the structures adjacent to the brain. Of these, primary cancers of the parenchyma are the least common, but can be the most difficult to treat. A number of unique challenges arise when the brain is invaded or compressed by a tumor. In addition to targeting the tumor for treatment, clinicians must manage symptomatic mass effect, use therapies that spare normal, eloquent brain while targeting tumor cells, and choose systemic therapies that traverse the blood–brain barrier. Although the more aggressive brain cancers remain incurable, an approach that balances the need to eliminate tumor cells with the need to minimize damage to the surrounding brain can markedly increase both quality and duration of life. This chapter discusses our clinical management of malignant brain tumors, using a multimodal approach that includes surgery, radiation, chemotherapy and medical symptom management. References1 Stummer W , Pichlmeier U , Meinel T et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre Phase III study . Lancet Oncol. 7 , 392 – 401 (2006) . Crossref, Medline, CAS, Google Scholar2 Sanai N , Polley MY , Mcdermott MW , Parsa AT , Berger MS . An extent of resection threshold for newly diagnosed glioblastomas . J. Neurosurgery 115 , 3 – 8 (2011) . Crossref, Medline, Google Scholar3 Smith JS , Chang EF , Lamborn KR et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas . J. Clin. Oncol. 26 , 1338 – 1445 (2008) . Crossref, Medline, Google Scholar4 Keime-Guibert F , Chinot O , Taillandier L et al. Radiotherapy for glioblastoma in the elderly . N. Engl. J. Med. 356 , 1527 – 1536 (2007) . Crossref, Medline, CAS, Google Scholar5 Stupp R , Hegi ME , Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC–NCIC trial . Lancet Oncol. 10 , 459 – 466 (2009) . Crossref, Medline, CAS, Google Scholar6 Lacroix M , Abi-Said D , Fourney DR et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival . J. Neurosurgery 95 , 190 – 198 (2001) . Crossref, Medline, CAS, Google Scholar7 Patchell RA , Tibbs PA , Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain . N. Engl. J. Med. 322 (8) , 494 – 500 (1990) . Crossref, Medline, CAS, Google Scholar8 Chang EL , Wefel JS , Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial . Lancet Oncol. 10 (11) , 1037 – 1044 (2009) . Crossref, Medline, Google Scholar9 Kocher M , Soffietti R , Abacioglu U et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 Study . J. Clin. Oncol. 29 (2) , 134 – 141 (2011) . Crossref, Medline, Google Scholar10 Patchell RA , Tibbs PA , Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial . JAMA 280 (17) , 1485 – 1489 (1998) . Crossref, Medline, CAS, Google Scholar11 Aoyama H , Shirato H , Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial . JAMA 295 (21) , 2483 – 2491 (2006) . Crossref, Medline, CAS, Google Scholar12 Mintz AH , Kestle J , Rathbone MP et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis . Cancer 78 (7) , 1470 – 1476 (1996) . Crossref, Medline, CAS, Google Scholar13 Sun A , Bae K , Gore EM et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis . J. Clin. Oncol. 29 (3) , 279 – 286 (2011) . Crossref, Medline, Google Scholar14 Li J , Bentzen SM , Renschler M , Mehta MP . Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function . J. Clin. Oncol. 25 (10) , 1260 – 1266 (2007) . Crossref, Medline, Google Scholar15 Soltys SG , Adler JR , Lipani JD et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases . Int. J. Radiat. Oncol. Biol. Phys. 70 (1) , 187 – 193 (2008) . Crossref, Medline, Google Scholar16 Choi CY , Chang SD , Gibbs IC et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control . Int. J. Radiat. Oncol. Biol. Phys. 84 (2) , 336 – 342 (2012) . Crossref, Medline, Google Scholar17 Choi CY , Chang SD , Gibbs IC et al. What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach . Int. J. Radiat. Oncol. Biol. Phys. 84 (3) , 688 – 693 (2012) . Crossref, Medline, Google Scholar18 Van Den Bent MJ , Afra D , De Witte O et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial . Lancet 366 (9490) , 985 – 990 (2005) . Crossref, Medline, CAS, Google Scholar19 Chalifoux R , Elisevich K . Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors . Stereotact. Funct. Neurosurg. 67 (3–4) , 169 – 182 (1996) . Medline, Google Scholar20 Pignatti F , Van Den Bent M , Curran D et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma . J. Clin. Oncol. 20 (8) , 2076 – 2084 (2002) . Crossref, Medline, Google Scholar21 Chang EL , Akyurek S , Avalos T et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma . Int. J. Radiat. Oncol. Biol. Phys. 68 (1) , 144 – 150 (2007) . Crossref, Medline, Google Scholar22 Minniti G , Amelio D , Amichetti M et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide . Radiother. Oncol. 97 (3) , 377 – 381 (2010) . Crossref, Medline, CAS, Google Scholar23 Adler JR Jr , Gibbs IC , Puataweepong P , Chang SD . Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions . Neurosurgery 59 (2) , 244 – 254 (2006) . Crossref, Medline, Google Scholar24 Tuniz F , Soltys SG , Choi CY et al. Multisession cyberknife stereotactic radiosurgery of large, benign cranial base tumors: preliminary study . Neurosurgery 65 (5) , 898 – 907 (2009) . Crossref, Medline, Google Scholar25 Muldoon LL , Soussain C , Jahnke K et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check . J. Clin. Oncol. 25 , 2295 – 2305 (2007) . Crossref, Medline, CAS, Google Scholar26 Hegi ME , Diserens A-C , Godard S et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide . Clin. Cancer Res. 10 , 1871 – 1874 (2004) . Crossref, Medline, CAS, Google Scholar27 Hegi ME , Diserens A-C , Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma . N. Engl. J. Med. 352 , 997 – 1003 (2005) . Crossref, Medline, CAS, Google Scholar28 Smith JS , Borell TJ , Lee HK et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas . J. Clin. Oncol. 18 , 636 – 645 (2000) . Crossref, Medline, CAS, Google Scholar29 Yung WK , Prados MD , Yava-Tur R et al. Multicener Phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group . J. Clin. Oncol. 17 , 2762 – 2771 (1999) . Crossref, Medline, CAS, Google Scholar30 Stupp R , Mason WP , Van Den Bent M et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma . N. Engl. J. Med. 352 , 987 – 996 (2005) . Crossref, Medline, CAS, Google Scholar31 Wick W , Platten M , Meisner C et al. Temozolomide chemotherapy versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, Phase 3 trial . Lancet Oncol. 13 (7) , 707 – 715 (2012) . Crossref, Medline, CAS, Google Scholar32 Antonadou A , Paraskevaidis M , Sarris G et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastates . J. Clin. Oncol. 20 , 3644 – 3650 (2003) . Crossref, Google Scholar33 Wolff JEA , Berrak S , Webb SE , Zhang M . Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients . J. Neurooncology 88 , 57 – 63 (2008) . Crossref, Medline, Google Scholar34 Van Den Bent M , Brandes AA , Rampling R et al. Randomized Phase II trial of erlotinib versus temozolomide or carmustine in recurrent gliolblastoma: EORTC Brain Tumor Group Study 26034 . J. Clin. Oncol. 27 , 1268 – 1274 (2009) . Crossref, Medline, CAS, Google Scholar35 Brem H , Piantadosi S , Burger PC et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas . Lancet 345 (8956) , 1008 – 1012 (1995) . Crossref, Medline, CAS, Google Scholar36 Vredenburgh JJ , Desjardins A , Herndon JE et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma . Clin. Cancer Res. 13 , 1253 – 1259 (2007) . Crossref, Medline, CAS, Google Scholar37 Vredenburgh JJ , Desjardins A , Herndon JE et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme . J. Clin. Oncol. 25 , 4722 – 4729 (2007) . Crossref, Medline, CAS, Google Scholar38 Nghiemphu P , Liu W , Lee Y et al. Bevacizumab and chemotherapy for recurrent glioblastoma. A single-institution experience . Neurology 72 , 1217 – 1222 (2009) . Crossref, Medline, CAS, Google Scholar39 Brandsma D , Stalpers L , Taal W , Sminia P , Van Den Bent M . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas . Lancet Oncol. 9 , 453 – 461 (2008) . Crossref, Medline, Google Scholar40 Levin VA , Bidaut L , Hou P et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system . Int. J. Radiat. Oncol. Biol. Phys. 79 (5) , 1487 – 1495 (2011) . Crossref, Medline, CAS, Google Scholar41 Nagpal S , Harsh G , Recht LD . Bevacizumab improves quality of life in patients with recurrent glioblastoma . Chemother. Res. Pract. 2011 , 1 – 6 (2012) . Crossref, Google Scholar42 Thiel E , Karfel A , Martus P et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a Phase 3, randomised, non-inferiority trial . Lancet Oncol. 11 , 1036 – 1047 (2010) . Crossref, Medline, CAS, Google Scholar43 Van Breemen MSM , Wilms EB , Vecht CJ . Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management . Lancet Neurol. 6 , 421 – 430 (2007) . Crossref, Medline, Google Scholar44 Klein M , Engelberts NH , Van Der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life . Ann. Neurol. 54 , 514 – 520 (2003) . Crossref, Medline, Google Scholar45 Hildebrand J , Lecaille C , Perennes J , Delattre JY . Epileptic seizures during follow-up of patients treated for primary brain tumors . Neurology 65 , 212 – 215 (2005) . Crossref, Medline, Google Scholar46 Duffau H , Capelle L , Lopes M , Bitar A , Sichez JP , Van Effenterre R . Medically intractable epilepsy from insular low-grade gliomas: improvements after an extended lesionectomy . Acta Neurochir. 144 , 563 – 572 (2002) . Crossref, Medline, CAS, Google Scholar47 Bauer R , Dobesberger J , Unterhofer C et al. Outcome of adult patients with temporal lobe tumours and medically refractory epilepsy . Acta Neurochir. 149 , 1211 – 1216 (2007) . Crossref, Medline, CAS, Google Scholar48 Rogers LR , Morris HH , Lupica K . Effect of cranial irradiation on seizure frequency in adults with low grade astrocytoma and medically intractable epilepsy . Neurology 43 , 1599 – 1601 (1993) . Crossref, Medline, CAS, Google Scholar49 Chalifoux R , Elisevich K . Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors . Stereotact. Funct. Neurosurg. 67 , 169 – 182 (1996) . Crossref, Medline, Google Scholar50 Sherman JH , Moldovan K , Yeoh HK et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas . J. Neurosurgery 114 , 1617 – 1621 (2011) . Crossref, Medline, Google Scholar51 Glantz MJ , Cole BF , Forsyth PA et al. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors . Neurology 54 , 1886 – 1893 (2000) . Crossref, Medline, CAS, Google Scholar52 Galicich JH , French LA . Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery . Am. Pract. Dig. Treat. 12 , 169 – 174 (1961) . Medline, CAS, Google Scholar53 Galicich JH , French LA , Melby JC . Use of dexamethasone in treatment of cerebral edema associated with brain tumors . J. Lancet 81 , 46 – 53 (1961) . Medline, CAS, Google Scholar54 Vecht CJ , Hovestadt A , Verbiest HB , van Vliet JJ , van Putten WL . Dose–effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day . Neurology 44 , 675 – 680 (1994) . Crossref, Medline, CAS, Google Scholar55 Marantidou A , Levy C , Duquesne A , Al . E Steroid requirements during radiotherapy for malignant gliomas . J. Neurooncol. 100 , 84 – 94 (2010) . Crossref, Google Scholar56 Batchelor TT , Taylor LP , Thaler HT , Posner JB , Deangelis L . Steroid myopathy in cancer patients . Neurology 48 , 1234 – 1238 (1997) . Crossref, Medline, CAS, Google Scholar57 Recht LD , Mechtler LL , Wong ET , O’Connor P , Rodda B . Steroid sparing effect of corticorelin acetate (CrA) in peritumoral cerebral edema is associated with improvement in steroid induced myopathy . J. Clin. Oncol. 31 (9) , 1182 – 1187 (2013) . Crossref, Medline, CAS, Google Scholar58 Tjuvajev J , Uehara H , Desai R et al. Corticotropin-releasing factor decreases vasogenic edema . Cancer Res. 56 , 1352 – 1360 (1996) . Medline, CAS, Google Scholar59 Gonzalez J , Kumar AJ , Conrad CA , Levin VA . Effect of bevacizumab on radiation necrosis of the brain . Int. J. Radiat. Oncol. Biol. Phys. 67 , 323 – 326 (2007) . Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Best Practices in Neurological CareMetrics Downloaded 13 times History Published online 4 February 2014 Published in print February 2014 Information© Future Medicine Ltd© Future Medicine LtdPDF download" @default.
• W2805081221 created "2018-06-13" @default.
• W2805081221 creator A5025685342 @default.
• W2805081221 creator A5034768472 @default.
• W2805081221 creator A5056495689 @default.
• W2805081221 creator A5069033960 @default.
• W2805081221 creator A5072792947 @default.
• W2805081221 date "2014-02-01" @default.
• W2805081221 modified "2023-09-27" @default.
• W2805081221 title "Brain tumor management" @default.
• W2805081221 cites W1516943082 @default.
• W2805081221 cites W1887747927 @default.
• W2805081221 cites W1967049179 @default.
• W2805081221 cites W1967156082 @default.
• W2805081221 cites W1973394201 @default.
• W2805081221 cites W1989416923 @default.
• W2805081221 cites W1990372004 @default.
• W2805081221 cites W1994374489 @default.
• W2805081221 cites W2002549507 @default.
• W2805081221 cites W2003917401 @default.
• W2805081221 cites W2018992636 @default.
• W2805081221 cites W2032090704 @default.
• W2805081221 cites W2032700496 @default.
• W2805081221 cites W2033434079 @default.
• W2805081221 cites W2038376591 @default.
• W2805081221 cites W2039978021 @default.
• W2805081221 cites W2047631667 @default.
• W2805081221 cites W2049344648 @default.
• W2805081221 cites W2050771499 @default.
• W2805081221 cites W2064214863 @default.
• W2805081221 cites W2067407840 @default.
• W2805081221 cites W2075270060 @default.
• W2805081221 cites W2079810642 @default.
• W2805081221 cites W2083564367 @default.
• W2805081221 cites W2086216067 @default.
• W2805081221 cites W2093641168 @default.
• W2805081221 cites W2093783077 @default.
• W2805081221 cites W2096287682 @default.
• W2805081221 cites W2105100844 @default.
• W2805081221 cites W2111042597 @default.
• W2805081221 cites W2113460821 @default.
• W2805081221 cites W2116165521 @default.
• W2805081221 cites W2116232743 @default.
• W2805081221 cites W2118311655 @default.
• W2805081221 cites W2119331159 @default.
• W2805081221 cites W2119838967 @default.
• W2805081221 cites W2120872266 @default.
• W2805081221 cites W2125372543 @default.
• W2805081221 cites W2125904639 @default.
• W2805081221 cites W2126959402 @default.
• W2805081221 cites W2127745545 @default.
• W2805081221 cites W2127941300 @default.
• W2805081221 cites W2128871519 @default.
• W2805081221 cites W2133611748 @default.
• W2805081221 cites W2134942438 @default.
• W2805081221 cites W2136963436 @default.
• W2805081221 cites W2141431050 @default.
• W2805081221 cites W2143843774 @default.
• W2805081221 cites W2151886675 @default.
• W2805081221 cites W2153273574 @default.
• W2805081221 cites W2154526619 @default.
• W2805081221 cites W2157006832 @default.
• W2805081221 cites W2158681922 @default.
• W2805081221 cites W2162872529 @default.
• W2805081221 cites W2163642916 @default.
• W2805081221 cites W2166400813 @default.
• W2805081221 cites W2166696317 @default.
• W2805081221 cites W2171165037 @default.
• W2805081221 cites W2177244913 @default.
• W2805081221 cites W2329793926 @default.
• W2805081221 cites W2766048157 @default.
• W2805081221 cites W2949679206 @default.
• W2805081221 cites W4249611430 @default.
• W2805081221 doi "https://doi.org/10.2217/ebo.13.309" @default.
• W2805081221 hasPublicationYear "2014" @default.
• W2805081221 type Work @default.
• W2805081221 sameAs 2805081221 @default.
• W2805081221 citedByCount "0" @default.
• W2805081221 crossrefType "other" @default.
• W2805081221 hasAuthorship W2805081221A5025685342 @default.
• W2805081221 hasAuthorship W2805081221A5034768472 @default.
• W2805081221 hasAuthorship W2805081221A5056495689 @default.
• W2805081221 hasAuthorship W2805081221A5069033960 @default.
• W2805081221 hasAuthorship W2805081221A5072792947 @default.
• W2805081221 hasConcept C41008148 @default.
• W2805081221 hasConceptScore W2805081221C41008148 @default.
• W2805081221 hasLocation W28050812211 @default.
• W2805081221 hasOpenAccess W2805081221 @default.
• W2805081221 hasPrimaryLocation W28050812211 @default.
• W2805081221 hasRelatedWork W2096946506 @default.
• W2805081221 hasRelatedWork W2130043461 @default.
• W2805081221 hasRelatedWork W2350741829 @default.
• W2805081221 hasRelatedWork W2358668433 @default.
• W2805081221 hasRelatedWork W2376932109 @default.
• W2805081221 hasRelatedWork W2382290278 @default.
• W2805081221 hasRelatedWork W2390279801 @default.
• W2805081221 hasRelatedWork W2748952813 @default.
• W2805081221 hasRelatedWork W2899084033 @default.

• next